Stuart Poulton

Insider Reports History

Location
Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stuart Poulton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stuart Poulton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, Chief Development Officer Common Stock 99,429 $858,072 $8.63 17 Feb 2026 Direct
Karyopharm Therapeutics Inc. EVP, Chief Development Officer Stock Option (right to buy) 9,166 28 Feb 2025 Direct

Insider Reports Filed by Stuart Poulton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 17 Feb 2026 1 -$3,262 4 EVP, Chief Development Officer 19 Feb 2026, 16:02
KPTI Karyopharm Therapeutics Inc. 31 Jan 2026 1 $0 4 EVP, Chief Development Officer 03 Feb 2026, 16:27
KPTI Karyopharm Therapeutics Inc. 15 Oct 2025 1 $0 4 EVP, Chief Development Officer 16 Oct 2025, 16:32
KPTI Karyopharm Therapeutics Inc. 12 Sep 2025 2 -$2,578 4 EVP, Chief Development Officer 16 Sep 2025, 16:33
KPTI Karyopharm Therapeutics Inc. 29 Jul 2025 1 -$835 4 EVP, Chief Development Officer 30 Jul 2025, 16:56
KPTI Karyopharm Therapeutics Inc. 04 Mar 2025 1 -$22,317 4 EVP, Chief Development Officer 06 Mar 2025, 16:24
KPTI Karyopharm Therapeutics Inc. 28 Feb 2025 4 $0 4 EVP, Chief Development Officer 04 Mar 2025, 16:51
KPTI Karyopharm Therapeutics Inc. 18 Feb 2025 1 -$3,726 4 EVP, Chief Development Officer 19 Feb 2025, 16:17
KPTI Karyopharm Therapeutics Inc. 30 Jul 2024 1 -$3,056 4 EVP, Chief Development Officer 31 Jul 2024, 16:14
KPTI Karyopharm Therapeutics Inc. 29 Feb 2024 2 -$26,470 4 EVP, Chief Development Officer 04 Mar 2024, 19:40
KPTI Karyopharm Therapeutics Inc. 28 Feb 2024 1 $0 4 EVP, Chief Development Officer 29 Feb 2024, 17:35
KPTI Karyopharm Therapeutics Inc. 15 Feb 2024 2 -$7,783 4 EVP, Chief Development Officer 20 Feb 2024, 16:59
KPTI Karyopharm Therapeutics Inc. 24 Jan 2024 1 $0 4 EVP, Chief Development Officer 25 Jan 2024, 19:14
KPTI Karyopharm Therapeutics Inc. 28 Jul 2023 1 -$4,836 4 EVP, Chief Development Officer 01 Aug 2023, 17:37
KPTI Karyopharm Therapeutics Inc. 28 Feb 2023 1 $0 4 EVP, Chief Development Officer 02 Mar 2023, 16:38
KPTI Karyopharm Therapeutics Inc. 15 Feb 2023 3 -$18,717 4 EVP, Chief Development Officer 17 Feb 2023, 15:07
KPTI Karyopharm Therapeutics Inc. 15 Aug 2022 0 $0 3 EVP, Chief Development Officer 19 Aug 2022, 16:15